A12594 | Pages: NA | Sep 2022 | 652 Views | ||
Author(s) : Onkar Sumant | Tables: NA | Charts: NA |
|
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Fluoro Enzymatic Assays Market
Request Now !Fluoro enzymatic assay is a biochemical procedure applied in immunology to recognize the presence of an antibody or antigen in a sample. Fluoro enzymatic assays are utilized as a diagnostic instrument in medicine and pathology, and a quality-control test over industries. These are mainly used for the measurement of markers of cardiac injury, drugs, specific proteins, hormones, and tumor markers. The rise in rate of infectious and chronic diseases and an increase in geriatric population have anticipated to drive the global fluoro enzymatic assay market growth.
Market Scope and Structure Analysis
Report Metric | Details |
 Market Size Available for Years |  2021–2030 |
 Base Year Considered |  2020 |
 Forecast Period |  2021–2030 |
 Forecast Unit |  Value (USD) |
 Segments Covered |  Product Type, Application, End User, and Region |
 Regions Covered |  North America, Europe, Asia-Pacific, and LAMEA |
 Companies Covered | Siemens Healthineers, BioMérieuxx, Becton, Dickinson & Company, Abbott laboratories, Danaher Corporation, Roche Diagnostics, Ortho Clinical Diagnostics, Thermo Fisher Scientific, Inc., Sysmex Corporation, and Quidel Corporation, |
COVID-19 Impact analysis
COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.
There has been an increase in the demand for medical supplies to take care of infected population. Respiratory support devices such as atomizers, life-support machines, oxygen generators, and monitors are among the majorly used medical devices in primary clinical treatment. Moreover, COVID-19 has led to a huge surge in demand for medical supplies such as personal protective equipment including masks, gloves, and protective eyeglasses. There is an increase in the need for medical supplies, both from healthcare professionals and civil population for precautionary measures, owing to the rise in number of COVID-19 cases worldwide. Manufacturers of these products have a chance to capitalize this increased demand for medical supplies to ensure adequate and continuous supply of personal protective equipment in the market. Therefore, COVID 19 is expected to have a significant impact on the fluoro enzymatic assays market.
Top Impacting Factors
Market Trends
New product launches to flourish the market
The key manufacturers are focusing on launching novel products to expand their footprints in the market and increase their revenue share.
In December 2018, Quidel’s product Sofia 2 Lyme+ FIA received a CE mark approval. Quidel Corporation is one of the major American manufacturers of diagnostic healthcare products. The product is to be used with a fluorescent immunoassay analyzer, Sofia 2.
In February 2021, Agilent Technologies Inc. declared the launch of Agilent Dako SARS-CoV-2, IgG Enzyme-Linked immunosorbent assay kit. It was made for the discovery of immunoglobulin G antibodies to SARS-CoV-2 in human plasma.
In April 2021, Bio-Rad Laboratories Inc. launched a blood-based immunoassay kit, to recognize antibodies to the corona virus SARS-CoV-2.
In April 2021, Roche Diagnostics launched Elecsys Anti-p53 immunoassay for the in vitro quantitative analysis of anti-p53 antibodies to assist the diagnosis of different types of cancer.
Key Segments Covered
Segment | Subsegment |
 Product Type |
|
 Application |
|
 End User |
|
 Region |
|
Key Benefits of the Report
Questions answered in the fluoro enzymatic assays Report
Key Market Segments & Key Market Players
Segments | Sub-segments |
---|---|
By Product Type |
|
By Application |
|
By End User |
|
By Region |
|
Key Market Players | Siemens Healthineers, BioMérieuxx, Becton, Dickinson and Company, Abbott laboratories, Danaher Corporation, Roche Diagnostics, Ortho Clinical Diagnostics, Thermo Fisher Scientific, Inc., Sysmex Corporation, Quidel Corporation |
Loading Table Of Content...
Start reading.
This Report and over 13,000+ more Reports, Available with Avenue Library. T&C*.
10%
Discount
10%
Discount
15%
Discount
15%
Discount
Enterprise
License/PDF
20%
Discount
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers